Table 4.
Relative expression level of serum lncRNA SNHG5 and its clinical significance in patients with gastric cancer (n)
| Clinical features | High expression | Low expression | χ2 | P |
|---|---|---|---|---|
| Gender | 0.38 | 0.536 | ||
| Male (n = 27) | 16 | 11 | ||
| Female (n = 23) | 13 | 10 | ||
| Age (years old) | 0.645 | 0.302 | ||
| ≤ 50 | 11 | 9 | ||
| > 50 | 13 | 17 | ||
| Drinking history | 9.443 | 0.03 | ||
| Yes | 5 | 26 | ||
| No | 11 | 8 | ||
| Smoking history | 1.705 | 0.175 | ||
| Yes | 13 | 20 | ||
| No | 10 | 7 | ||
| Tumor size (cm) | 0.198 | 0.454 | ||
| ≤ 5 | 5 | 10 | ||
| > 5 | 14 | 21 | ||
| Lymphatic metastasis | 0.30 | 0.403 | ||
| Yes | 10 | 25 | ||
| No | 5 | 10 | ||
| TNM stage | 4.987 | 0.026 | ||
| I-II stage | 12 | 14 | ||
| III-IV stage | 4 | 20 |